These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27376025)

  • 1. Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain.
    Coyne KS; Sexton C; LoCasale RJ; King FR; Margolis MK; Ahmedzai SH
    Front Oncol; 2016; 6():131. PubMed ID: 27376025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review.
    Coyne KS; LoCasale RJ; Datto CJ; Sexton CC; Yeomans K; Tack J
    Clinicoecon Outcomes Res; 2014; 6():269-81. PubMed ID: 24904217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use.
    LoCasale RJ; Datto CJ; Margolis MK; Tack J; Coyne KS
    Int J Clin Pract; 2015 Dec; 69(12):1448-56. PubMed ID: 26344578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
    LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-Induced Constipation Among Patients with Chronic Noncancer Pain in the United States, Canada, Germany, and the United Kingdom: Laxative Use, Response, and Symptom Burden Over Time.
    Coyne KS; Margolis MK; Yeomans K; King FR; Chavoshi S; Payne KA; LoCasale RJ
    Pain Med; 2015 Aug; 16(8):1551-65. PubMed ID: 25802051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation.
    LoCasale RJ; Datto C; Margolis MK; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):246-53. PubMed ID: 27003554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laxative utilization over time in chronic pain patients with opioid-induced constipation.
    Datto CJ; LoCasale RJ; Margolis MK; Thompson CL; Coyne KS
    Pain Manag; 2016 Nov; 6(6):531-541. PubMed ID: 27476539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer.
    Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A
    J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
    Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
    Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey.
    Gupta S; Patel H; Scopel J; Mody RR
    J Opioid Manag; 2015; 11(4):325-38. PubMed ID: 26312960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study.
    Brown TJ; Keshvani N; Gupta A; Yang H; Agrawal D; Le TC; Gerber DE; Alvarez CA
    Support Care Cancer; 2020 Nov; 28(11):5315-5321. PubMed ID: 32124025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate response.
    Tack J; Lappalainen J; Diva U; Tummala R; Sostek M
    United European Gastroenterol J; 2015 Oct; 3(5):471-80. PubMed ID: 26535126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience.
    Coyne KS; Currie BM; Holmes WC; Crawley JA
    Patient; 2015 Aug; 8(4):317-27. PubMed ID: 25231829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
    Cobo Dols M; Beato Zambrano C; Cabezón Gutiérrez L; Chicas Sett R; Blancas López-Barajas MI; García Navalón F; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Jiménez López AJ; Huerta González I; Sanz Yagüe A; Soler López B
    BMJ Support Palliat Care; 2021 Mar; 11(1):25-31. PubMed ID: 32376758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating Clinical Findings into the Patient's Perspective: Post-hoc Pooled Analysis of Bowel Movement Changes as a Predictor of Improvement in Patients' Opioid-induced Constipation Symptoms and Outcomes.
    Coyne KS; Poon JL; Thompson C; Hu Y; Datto CJ; Sostek M
    Clin Ther; 2017 Jan; 39(1):75-88. PubMed ID: 27938897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer.
    Harada T; Imai H; Fumita S; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A
    Int J Clin Oncol; 2021 Jan; 26(1):104-110. PubMed ID: 33068220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study.
    Abramowitz L; Béziaud N; Labreze L; Giardina V; Caussé C; Chuberre B; Allaert FA; Perrot S
    J Med Econ; 2013 Dec; 16(12):1423-33. PubMed ID: 24102123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.
    Koopmans G; Simpson K; De Andrés J; Lux EA; Wagemans M; Van Megen Y
    Curr Med Res Opin; 2014 Nov; 30(11):2389-96. PubMed ID: 25265132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.